BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1980709)

  • 1. [Prolactinoma is more frequent among men than among women. A dopamine agonist is effective in the treatment].
    Hulting AL; Muhr C; Lundberg PO; Werner S
    Lakartidningen; 1990 Dec; 87(50):4335-7. PubMed ID: 1980709
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prolactinoma with a new dopamine agonist].
    Svoboda T; Luger A; Knosp E; Geyer G
    Dtsch Med Wochenschr; 1991 Aug; 116(33):1224-7. PubMed ID: 1678695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The best approach to treat prolactinoma].
    Zárate A; Saucedo R; Basurto L
    Gac Med Mex; 2004; 140(5):567-9. PubMed ID: 15559242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of prolactinoma].
    Serri O; Somma M; Beauregard H; Rasio E; Comtois R; Aris-Jilwan N; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):496-9. PubMed ID: 7905686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy of prolactinomas.
    Jaquet P
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():31-3. PubMed ID: 8103957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case].
    García Calzado MC; Ruiz Buendía A
    Rev Clin Esp; 1992 Jun; 191(2):112-3. PubMed ID: 1502384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statistical survey of prolactin producing tumor in Japan].
    Katayanagi N; Miyachi Y
    Nihon Rinsho; 1993 Jan; 51 Suppl():33-8. PubMed ID: 8459560
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nursing care of pituitary prolactinoma with bromocriptine].
    Zhong Y; Yuang BN
    Zhonghua Hu Li Za Zhi; 1993 May; 28(5):270-1. PubMed ID: 8258164
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of micro- and macroprolactinoma. Must dopamine agonists be given lifelong?].
    von Werder K
    Dtsch Med Wochenschr; 1991 Jan; 116(1):25-7. PubMed ID: 1670764
    [No Abstract]   [Full Text] [Related]  

  • 13. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of bromocriptine during pregnancy and appearance of partial empty sella turcica in women with prolactinoma].
    López de la Torre Casares M; Rodríguez Poyo-Guerrero P; Garrido Pérez M; Moreno Esteban B
    Rev Clin Esp; 1991 Nov; 189(7):343-4. PubMed ID: 1767093
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnancy in a patient with prolactinoma off treatment.
    Sood A; Kalra S; Gulati MS; Mittal S
    J Assoc Physicians India; 2000 Dec; 48(12):1221. PubMed ID: 11280238
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
    Zhang HW; Yu CJ; Sun W; Yang J; Yan CX; Cun EH
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(22):1555-7. PubMed ID: 17359664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural study of prolactinoma after bromocriptine therapy.
    Wang CJ; Howng SL
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Dec; 4(12):660-6. PubMed ID: 3251048
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study.
    Nickelsen T; Jungmann E; Althoff P; Schumm-Draeger PM; Usadel KH
    Arzneimittelforschung; 1993 Apr; 43(4):421-5. PubMed ID: 8098604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical treatment of prolactinoma. Quo usque tandem..].
    Elsässer Imboden PN; Gomez F
    Rev Med Suisse; 2005 Feb; 1(6):440-5. PubMed ID: 15786649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macroprolactinoma reduction and pregnancy induction with bromocriptine].
    Grimaldo J; López Espinoza E; Villanueva C; Verulo Reyes TB; Ayala AR
    Ginecol Obstet Mex; 1988 Aug; 56():213-7. PubMed ID: 3154241
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.